These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24366051)

  • 21. Measures to assess the prognostic ability of the stratified Cox proportional hazards model.
    Fibrinogen Studies Collaboration
    Stat Med; 2009 Feb; 28(3):389-411. PubMed ID: 18833567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single and multiple cardiovascular biomarkers in subjects without a previous cardiovascular event.
    Pareek M; Bhatt DL; Vaduganathan M; Biering-Sørensen T; Qamar A; Diederichsen AC; Møller JE; Hindersson P; Leósdóttir M; Magnusson M; Nilsson PM; Olsen MH
    Eur J Prev Cardiol; 2017 Oct; 24(15):1648-1659. PubMed ID: 28644092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population: results from the 14-year follow-up of a large cohort from southern Germany.
    Koenig W; Khuseyinova N; Löwel H; Trischler G; Meisinger C
    Circulation; 2004 Oct; 110(14):1903-8. PubMed ID: 15451783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of the addition of beta-2-microglobulin, cystatin C and C-reactive protein to an established risk factors model to improve mortality risk prediction in patients undergoing coronary angiography.
    Nead KT; Zhou MJ; Caceres RD; Sharp SJ; Wehner MR; Olin JW; Cooke JP; Leeper NJ
    Am J Cardiol; 2013 Mar; 111(6):851-6. PubMed ID: 23290308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and validation of modified risk prediction models for cardiovascular disease and its subtypes: The Hisayama Study.
    Honda T; Yoshida D; Hata J; Hirakawa Y; Ishida Y; Shibata M; Sakata S; Kitazono T; Ninomiya T
    Atherosclerosis; 2018 Dec; 279():38-44. PubMed ID: 30408715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.
    ; Danesh J; Lewington S; Thompson SG; Lowe GD; Collins R; Kostis JB; Wilson AC; Folsom AR; Wu K; Benderly M; Goldbourt U; Willeit J; Kiechl S; Yarnell JW; Sweetnam PM; Elwood PC; Cushman M; Psaty BM; Tracy RP; Tybjaerg-Hansen A; Haverkate F; de Maat MP; Fowkes FG; Lee AJ; Smith FB; Salomaa V; Harald K; Rasi R; Vahtera E; Jousilahti P; Pekkanen J; D'Agostino R; Kannel WB; Wilson PW; Tofler G; Arocha-Piñango CL; Rodriguez-Larralde A; Nagy E; Mijares M; Espinosa R; Rodriquez-Roa E; Ryder E; Diez-Ewald MP; Campos G; Fernandez V; Torres E; Marchioli R; Valagussa F; Rosengren A; Wilhelmsen L; Lappas G; Eriksson H; Cremer P; Nagel D; Curb JD; Rodriguez B; Yano K; Salonen JT; Nyyssönen K; Tuomainen TP; Hedblad B; Lind P; Loewel H; Koenig W; Meade TW; Cooper JA; De Stavola B; Knottenbelt C; Miller GJ; Cooper JA; Bauer KA; Rosenberg RD; Sato S; Kitamura A; Naito Y; Palosuo T; Ducimetiere P; Amouyel P; Arveiler D; Evans AE; Ferrieres J; Juhan-Vague I; Bingham A; Schulte H; Assmann G; Cantin B; Lamarche B; Després JP; Dagenais GR; Tunstall-Pedoe H; Woodward M; Ben-Shlomo Y; Davey Smith G; Palmieri V; Yeh JL; Rudnicka A; Ridker P; Rodeghiero F; Tosetto A; Shepherd J; Ford I; Robertson M; Brunner E; Shipley M; Feskens EJ; Kromhout D; Dickinson A; Ireland B; Juzwishin K; Kaptoge S; Lewington S; Memon A; Sarwar N; Walker M; Wheeler J; White I; Wood A
    JAMA; 2005 Oct; 294(14):1799-809. PubMed ID: 16219884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Building prediction models for coronary heart disease by synthesizing multiple longitudinal research findings.
    Hu G; Root MM
    Eur J Cardiovasc Prev Rehabil; 2005 Oct; 12(5):459-64. PubMed ID: 16210932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meta-analysis of non-linear exposure-outcome relationships using individual participant data: A comparison of two methods.
    White IR; Kaptoge S; Royston P; Sauerbrei W;
    Stat Med; 2019 Feb; 38(3):326-338. PubMed ID: 30284314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C-reactive protein, fatal and nonfatal coronary artery disease, stroke, and peripheral artery disease in the prospective EPIC-Norfolk cohort study.
    van Wijk DF; Boekholdt SM; Wareham NJ; Ahmadi-Abhari S; Kastelein JJ; Stroes ES; Khaw KT
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2888-94. PubMed ID: 24072695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association Between High-Sensitivity Cardiac Troponin I and Cardiac Events in Elderly Women.
    Lewis JR; Lim WH; Wong G; Abbs S; Zhu K; Lim EM; Thompson PL; Prince RL
    J Am Heart Assoc; 2017 Jul; 6(8):. PubMed ID: 28757482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C-reactive protein, fibrinogen, and cardiovascular disease prediction.
    ; Kaptoge S; Di Angelantonio E; Pennells L; Wood AM; White IR; Gao P; Walker M; Thompson A; Sarwar N; Caslake M; Butterworth AS; Amouyel P; Assmann G; Bakker SJ; Barr EL; Barrett-Connor E; Benjamin EJ; Björkelund C; Brenner H; Brunner E; Clarke R; Cooper JA; Cremer P; Cushman M; Dagenais GR; D'Agostino RB; Dankner R; Davey-Smith G; Deeg D; Dekker JM; Engström G; Folsom AR; Fowkes FG; Gallacher J; Gaziano JM; Giampaoli S; Gillum RF; Hofman A; Howard BV; Ingelsson E; Iso H; Jørgensen T; Kiechl S; Kitamura A; Kiyohara Y; Koenig W; Kromhout D; Kuller LH; Lawlor DA; Meade TW; Nissinen A; Nordestgaard BG; Onat A; Panagiotakos DB; Psaty BM; Rodriguez B; Rosengren A; Salomaa V; Kauhanen J; Salonen JT; Shaffer JA; Shea S; Ford I; Stehouwer CD; Strandberg TE; Tipping RW; Tosetto A; Wassertheil-Smoller S; Wennberg P; Westendorp RG; Whincup PH; Wilhelmsen L; Woodward M; Lowe GD; Wareham NJ; Khaw KT; Sattar N; Packard CJ; Gudnason V; Ridker PM; Pepys MB; Thompson SG; Danesh J
    N Engl J Med; 2012 Oct; 367(14):1310-20. PubMed ID: 23034020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive accuracy of novel risk factors and markers: A simulation study of the sensitivity of different performance measures for the Cox proportional hazards regression model.
    Austin PC; Pencinca MJ; Steyerberg EW
    Stat Methods Med Res; 2017 Jun; 26(3):1053-1077. PubMed ID: 25656552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coronary disease risk prediction algorithm warranting incorporation of C-reactive protein in Turkish adults, manifesting sex difference.
    Onat A; Can G; Hergenç G; Uğur M; Yüksel H
    Nutr Metab Cardiovasc Dis; 2012 Aug; 22(8):643-50. PubMed ID: 21315565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data.
    ; Wensley F; Gao P; Burgess S; Kaptoge S; Di Angelantonio E; Shah T; Engert JC; Clarke R; Davey-Smith G; Nordestgaard BG; Saleheen D; Samani NJ; Sandhu M; Anand S; Pepys MB; Smeeth L; Whittaker J; Casas JP; Thompson SG; Hingorani AD; Danesh J
    BMJ; 2011 Feb; 342():d548. PubMed ID: 21325005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Circulating Metabolites With Risk of Coronary Heart Disease in a European Population: Results From the Biomarkers for Cardiovascular Risk Assessment in Europe (BiomarCaRE) Consortium.
    Cavus E; Karakas M; Ojeda FM; Kontto J; Veronesi G; Ferrario MM; Linneberg A; Jørgensen T; Meisinger C; Thorand B; Iacoviello L; Börnigen D; Woodward M; Schnabel R; Costanzo S; Tunstall-Pedoe H; Koenig W; Kuulasmaa K; Salomaa V; Blankenberg S; Zeller T;
    JAMA Cardiol; 2019 Dec; 4(12):1270-1279. PubMed ID: 31664431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fatty liver disease: Disparate predictive ability for cardiometabolic risk and all-cause mortality.
    Onat A; Can G; Kaya A; Akbaş T; Özpamuk-Karadeniz F; Şimşek B; Çakır H; Yüksel H
    World J Gastroenterol; 2015 Dec; 21(48):13555-65. PubMed ID: 26730168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-terminal probrain natriuretic peptide and C-reactive protein in stable coronary heart disease.
    Ndrepepa G; Kastrati A; Braun S; Mehilli J; Niemöller K; von Beckerath N; von Beckerath O; Vogt W; Schömig A
    Am J Med; 2006 Apr; 119(4):355.e1-8. PubMed ID: 16564781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic markers enhance coronary risk prediction in men: the MORGAM prospective cohorts.
    Hughes MF; Saarela O; Stritzke J; Kee F; Silander K; Klopp N; Kontto J; Karvanen J; Willenborg C; Salomaa V; Virtamo J; Amouyel P; Arveiler D; Ferrières J; Wiklund PG; Baumert J; Thorand B; Diemert P; Trégouët DA; Hengstenberg C; Peters A; Evans A; Koenig W; Erdmann J; Samani NJ; Kuulasmaa K; Schunkert H
    PLoS One; 2012; 7(7):e40922. PubMed ID: 22848412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A heart failure phenotype stratified model for predicting 1-year mortality in patients admitted with acute heart failure: results from an individual participant data meta-analysis of four prospective European cohorts.
    Chen Y; Voors AA; Jaarsma T; Lang CC; Sama IE; Akkerhuis KM; Boersma E; Hillege HL; Postmus D
    BMC Med; 2021 Jan; 19(1):21. PubMed ID: 33499866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.